Total | Group A | Group B | P | |
---|---|---|---|---|
Patients (n) | 175 | 95 (54.3%) | 80 (45.7%) | – |
Age (years) | 52.8 ± 11.8 | 53.9 ± 11.4 | 50.1 ± 12.4 | .919 |
Male (n%) | 138 (78.9%) | 73 | 65 | .477 |
Diabetes (n%) | 29 (16.6%) | 16 | 13 | .916 |
Hypertension (n%) | 143 (81.7%) | 76 | 67 | .523 |
Hyperlipidemia (n%) | 33 (18.9%) | 18 | 15 | .973 |
Coronary heart disease (n%) | 10 (5.7%) | 4 | 6 | .349 |
Renal dysfunctiona (n%) | 40 (22.9%) | 18 | 22 | .180 |
COPD (n%) | 10 (5.7%) | 4 | 6 | .349 |
Moderate or severe aortic valve regurgitation (n%) | 61 (34.9%) | 30 | 31 | .321 |
LVEF (%) | 62.1 ± 9.5 | 62.3 ± 11.6 | 64.1 ± 9.9 | .230 |
Heart rate | 85.8 ± 14.5 | 80.9 ± 13.9 | 86.5 ± 14.2 | .390 |
Malperfusion syndromes (n%) | 26 (14.9%) | 13 | 13 | .634 |